Trade Mark Journal No.2024/020 17 May 2024

UK00004047234 3 May 2024 (5)

IMCLISFA

International priority date claimed: 6 November 2023 (United States of America) (98257351)

Class 5: Pharmaceutical and biological preparations; Pharmaceutical and biological preparations for use in oncology; Pharmaceutical and biological preparations for preventing, diagnosing, treating and managing cancer, tumors, melanoma, and carcinoma; Pharmaceutical and biological preparations for preventing, diagnosing, treating and managing metastatic uveal melanoma, primary uveal melanoma, and cutaneous melanoma; Therapeutic agents for targeting genetically defined cancers or tumors having GNAQ or GNA11 gene mutations, and destruction of diseased cells, for medical treatment purposes.

Ideaya Biosciences, Inc.

Representative: Page, White & Farrer Limited